Clinical Trials Directory

Trials / Completed

CompletedNCT00002576

Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma

A RANDOMIZED PROSPECTIVE TRIAL OF CHOP VERSUS MCOP IN ELDERLY PATIENTS WITH INTERMEDIATE AND HIGH GRADE NON-HODGKIN'S LYMPHOMA (AGED 65 YEARS AND OVER)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Cancer Research Campaign Clinical Trials Centre · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy consisting of cyclophosphamide, vincristine, and prednisolone, with either mitoxantrone or doxorubicin in treating patients with intermediate- or high-grade non-Hodgkin's lymphoma.

Detailed description

OBJECTIVES: I. Assess the treatment-related neurologic and hematologic toxicities of patients aged 65 years and over with intermediate- or high-grade non-Hodgkin's lymphoma randomized to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) vs. MCOP (mitoxantrone, cyclophosphamide, vincristine, prednisolone). II. Compare the survival rate in these patients. OUTLINE: Randomized study. The following acronyms are used: CHOP CTX/DOX/VCR/PRDL CTX Cyclophosphamide, NSC-26271 DHAD Mitoxantrone, NSC-301739 DOX Doxorubicin, NSC-123127 MCOP DHAD/CTX/VCR/PRDL PRDL Prednisolone, NSC-9900 VCR Vincristine, NSC-67574 Arm I: 4-Drug Combination Chemotherapy. CHOP. Arm II: 4-Drug Combination Chemotherapy. MCOP. PROJECTED ACCRUAL: A total of 200 patients will be entered over approximately 5 years.

Conditions

Interventions

TypeNameDescription
DRUGcyclophosphamide
DRUGdoxorubicin hydrochloride
DRUGmitoxantrone hydrochloride
DRUGprednisolone
DRUGvincristine sulfate

Timeline

Start date
1992-11-01
Completion
2001-01-01
First posted
2004-05-24
Last updated
2013-08-07

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00002576. Inclusion in this directory is not an endorsement.